All News

Oncology nurse Heather Hannon offers tips and suggestion about what's best to bring to treatment, so you have your chemotherapy infusions in comfort, and pass the time peacefully.

“The cancer care community urgently needs data on the effects of COVID-19, specifically in patients with cancer,” ASCO President Dr. Howard A. Burris III said in a press release.

New findings suggest that patients with thoracic cancer who receive chemotherapy three months after a COVID-19 diagnosis may have an increased risk of death compared to similar patients who underwent different treatment.

Here is a list of the recent trial initiations that occurred within the cancer space in May.

Dealing with the challenges of health and wellness after cancer treatment is tricky enough, but managing it in the midst of the COVID-19 pandemic is an even bigger obstacle. One survivor details how she tries to take it one wellness win at a time.

“Being a caregiver is a role that is defined by cancer more so than it is by the caregiver.”

The Food and Drug Administration approved the combination of Opdivo and Yervoy with 2 cycles of chemotherapy as a first-line treatment for certain patients with metastatic non-small cell lung cancer.

Chemotherapy killed my veins, and quarterly blood tests won't let me forget that. How it's impossible to ever forget the changes cancer brings.

One cancer survivor details protecting the story of other survivors from those who would sensationalize it.

A cancer survivor describes the changes of going for treatment during the pandemic.

During Skin Cancer Awareness Month, one melanoma survivor reflects on her treatment and the preventive measures everyone should take to avoid skin cancer.

The Food and Drug Administration approved Alunbrig for the first-line treatment of patients with ALK-positive metastatic non–small cell lung cancer.

Receiving a cancer diagnosis is scary enough, but amid the COVID-19 pandemic it has even more challenges. But cancer survivors can help ease their worries by listening and sharing their experiences.

From Johnson & Johnson discontinuing their talc-based baby powder in the U.S. and Canada after numerous lawsuits that cited the talc, a mineral similar to asbestos, caused cancer, to the ramifications of delayed cancer surgeries being felt by patients, here’s everything happening in the cancer space this week.

The Food and Drug Administration’s approval of the PARP inhibitor Lynparza for patients with metastatic prostate cancer gives a smaller subgroup of patients another treatment option if hormonal therapies do not work.

“Those who are doing well and are stable in terms of safety and tolerability can come into the office less often,” Dr. David R. Spigel, said. “(This is) a big win.”

Vitamin D is vital for anyone, but for people with cancer it can be especially vital even during social distancing rules.

The Food and Drug Administration recently approved the combination of Lynparza (olaparib) and Avastin (bevacizumab) for patients with advanced ovarian cancer that carries a specific mutation and has responded to previous treatment with platinum-based chemotherapy plus Avastin. Here’s what you need to know.

The Food and Drug Administration continues to approve cancer therapies amid the COVID-19 pandemic. Here are five approvals that patients with cancer may have missed.

It's not just time spent sitting in the lobby. Waiting is a way of life for people with cancer.

“For the patients that are nervous about how this is going to end, or what's going to happen, I would say that that's true for them outside of the COVID crisis because that's the same question they have about their cancer,” Dr. Scott A. Irwin said.

Dr. Brian Rini discussed the benefits of treating patients with relapsed or refractory renal cell carcinoma with the vascular endothelial growth factor tyrosine kinase inhibitor.

The Food and Drug Administration gave the green light to the PARP inhibitor Lynparza for men with metastatic castration-resistant prostate cancer that has a defective DNA-repair process and has progressed after treatment with the novel hormone-controlling drugs Xtandi (enzalutamide) or Zytiga (abiraterone acetate).

The Food and Drug Administration’s recent approval of Zejula is different from previous approvals as it is indicated for all patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer, according to a gynecologic oncology expert.

As stress and anxiety have increased during the COVID-19 pandemic, one expert notes how it’s important for patients with cancer to pay attention to their mental health.

Do parts of being in a pandemic feel familiar to you? Yet you have never been in one before? One cancer survivor suggests that's because those who have been on the cancer journey have experienced this before.

Tecentriq is approved as an initial treatment for non-small cell lung cancer that has spread and expresses the protein PD-L1 but does not have alterations in the EGFR or ALK genes.

Precision medicine is improving outcomes for aggressive types of lymphomas, such as mantle cell lymphoma.

COVID-19 has dramatically altered the lives of millions across the globe, but for patients with cancer, the new restrictions and new challenges are ones they have already managed to handle.

Patients with cancer have a unique skill that not only aids them through their own cancer journey but a global pandemic like COVID-19.